Medicine Information

Thalidomide


Thalidomide is responsible for causing more than 10,000 children to be born with birth defects.

A West German Pharmaceutical Company first introduced Thalidomide as a sedative or sleep aid in 1957, and scientific testing determined that Thalidomide was safe, before it was introduced.

Thalidomide is dangerous (an understatement) and it is being prescribed even today. Thalidomide is being tested and has been used as a part of a drug (cocktail) to treat ADHD.

The Medical (North American Health Care Industry) presents itself as the scientific way to health. However, their methods are not necessarily scientific in the application of its form of health care. Industries must make money to survive, and the Medical as an industry, can be ruthless in its drive to make a profit.

Thalidomide ranks with and should elicit the same negative memory response as: dioxin, carcinogen and poison.

Soon after Thalidomide was released, reports started to come back to the company of instances of neuritis, because Thalidomide had a toxic effect on the nervous system of the user. Thalidomide was first used as a sleep aid or sedative and was available and widely used in Germany, Canada, Japan, Bolivia and Britain. Other countries had access to the drug; however, it was mainly contained in those countries.

John Parsons
Read more at http://www.corporatenarc.com


MORE RESOURCES:

MiamiHerald.com

Book clubs for doctors show human side of medicine
The Associated Press
Verghese agreed that patient empathy is at the heart of the humanities in medicine movement. He also advocated for a more physician-centric outlook. ...
Book clubs for doctors show human side of medicineNewsday (subscription)
Book clubs for doctors show human side of medicinePennLive.com

all 218 news articles »


Medicine's Future Could Lie in Each Patient's Genome
U.S. News & World Report
"This is another milestone in the inevitable march towards personalized genetic health," said Dr. Robert Marion, chief of genetics and development medicine ...

and more »


Reuters

Five new human genomes decoded, marking a transition to more personalized medicine
Los Angeles Times (blog)
Dr. James Lupski of the Baylor College of Medicine in Houston was diagnosed with Charcot-Marie-Tooth disease in his teens, as were three of his seven ...
Sequencing of patients' genomes offers new hope: studiesAFP
The future of medicine has arrivedIndependent
MD finds his family's rare disorder in genomeCBC.ca
Popular Science -GenomeWeb Daily News -New York Times
all 183 news articles »


Dangerous medicine
Sify
Chinese inflation: Inflationary days are back in China. Prices rose 2.7 per cent in February, compared to a year earlier, driven by food prices, ...

and more »


TheHorse.com

Speakers to Focus on Translating Regenerative Medicine Science
Newswise (press release)
Newswise — What regenerative medicine therapies are being applied to patients today? What hurdles stand between stem cell therapies and real treatments in ...
STEM CELLSSanta Ynez Valley Journal
Regenerative Medicine Conference Attracts Vets, ResearchersTheHorse.com
Regenerative Medicine & Stem Cell(RMSC)PharmiWeb.com (press release)
MSN Money -San Diego Business Journal -UC Davis
all 54 news articles »


Medco amps up personalized medicine program
FiercePharma
The "personalized medicine" move is designed to target prescriptions to patients who really will benefit from them, saving money and improving healthcare in ...
Personalized Medicine Spurred by Medco's Gene TestingBusinessWeek

all 4 news articles »


Reimer: Acupuncture seems to help where modern medicine failed
Baltimore Sun
Traditional medicine - from podiatrists to orthopedic surgeons - has failed to relieve the pain in my joints caused by years of wear and tear, so I followed ...

and more »


MEDNAX Announces Expansion in Maryland with Acquisition of Maternal-Fetal ...
MarketWatch (press release)
... (NYSE:MD) today announced the acquisition of Maryland Perinatal Associates, PC, a group of four maternal-fetal medicine physicians based in Rockville, ...
Mednax acquires Maryland practiceSouth Florida Business Journal

all 26 news articles »


USC News

Medicine in the dark
Los Angeles Times
Michael Hochman, MD, is an assistant professor of clinical medicine at USC's Keck School of Medicine. Danny McCormick, MD, MPH, is an assistant professor of ...
Few Studies Compare the Efficacy of Medical TreatmentsScientific American
Most Drug Studies Don't Help Docs Pick Best TreatmentBusinessWeek
Charting a Path From Comparative Effectiveness Funding to Improved Patient ...Journal of American Medical Association (subscription)
Scientific Frontline -Nature.com (subscription) (blog)
all 39 news articles »


TopNews United States

Should I Get the Prostate Cancer Test?
New York Times
Dr. Ablin cites two studies, each reported in The New England Journal of Medicine, to support his contention regarding the lack of utility of PSA screening. ...
PSA Discoverer Says PSA Screening is "Public Health Disaster"Medscape
Prostate cancer and menHartford Courant (blog)

all 17 news articles »

Google News

home | site map
©EmptyNestNow.com 2006